The Director, Value Strategy and Evidence, Oncology is an integral member of the U.S. Market Access organization and is responsible for the development and implementation of bespoke innovative reimbursement and payment models (i.e., Innovative Value Strategies (IVS) at key customers within the U.S. business. 

The Director will closely partner with peer colleagues across numerous functions (namely, Contract Strategy, National and Regional Account Teams, Medical Affairs, Global R&D, Access Strategy, Data Science, Actuary, HEOR, and Global Pricing Strategy, Insights & Analytics, Government Affairs & Policy).  She/hewill be responsible for synthesizing clinical trial data, real world evidence, and competitive market intelligence, while ascertaining value drivers for payer and health system customers.  The director will create IVS frameworks (e.g., value-based contracts) and own end-to end development, market implementation, adjudication, outcomes and financial reporting to support brand access strategies at launch and throughout the product life cycle. Specific responsibilities of the role include: 

• Synthesis of Evidence & Gap Analysis/Environmental Analysis: 

• Lead cross-functional working groups to develop IVS for oncology brands

• Analyzing RCT/RWE/HEOR & other data

• Writing protocols for data extraction and synthesis 

• Conducting market and reimbursement landscapeassessments and health policy research

• Developing innovative, value-based, and/or outcomes-based constructs aligned to brand priorities

• Construction of IVS Frameworks: 

• Conducting market research

• Building analytic models

• Creating presentation materials & related documents 

• Achieving organizational alignment for IVS constructs

• IVS Implementation (Payer Analytics Coordination & Outcomes Reporting):

• Leadingcustomer engagement 

• Providing analytic consultation 

• Adjudicating outcomes and financial results 

• Conducting performance reviews with internal and external stakeholders

• Publishing results in leading journals as appropriate

The Director will be a strategic, high- performing, independent, self-starting leader with clinical and business-focused technical training.  The director will also have demonstrated experience analyzing TPPs, applying HEOR/RWE, and building analytic models for purposes of delivering strategic market access solutions (payer-facing experience is strongly preferred). Strong communication skills, business acumen, and ability to influence without authority in a matrix environment is essential.  Proficiency in using AI, Excel, PowerPoint, and other productivity and project management software is essential.A working knowledge/understanding of actuarial analysis and financial modeling is required.

Demonstrated Abilities and Performance Indicators:

• Analytic rigor

• Clinical training (oncology preferred)

• Demonstrated business acumen

• Strong verbal and written communication skills

• Demonstrated leadership in a matrix environment

• Highly motivated

• Expertise in US healthcare market(care delivery, pharmaceutical reimbursement, insurance design, commercial and government segnments, oncology focus)

• Manages stakeholder expectations across a large corporate matrix

• Navigates ambiguity with ease

• Champions innovation 

• Self-starting, independent, entrepreneurial demeanor who thrives on new challenges

• Strategic thinker

• Executive presence and effectively communicates complex topics to senior executives

• Self-aware and willingness to be coached, accept feedback

• Influences without authority 

Education & Training:

• PhDor Masters degree in a scientific and/or business discipline is required. (e.g., MBA, MPH, PhD in Clinical Research/HEOR/Biostatistics/Epidemiology/Health Services Research) 

Experience:

• Minimum of 7 years pharmaceutical/medical device experience required with demonstrated capabilities in access strategy, contracting, pricing, HEOR/RWE, medical/R&D, new product planning (customer-facing experience highly desired)

• 5 years(preferred) market access experience (within pharma/medical device or in consulting capacity)

• Understanding of the U.S. healthcare reimbursement landscape, payer segments, and evolving market access reforms and reimbursement trends

• Demonstrated ability to thrive in a matrix environment, and to manage multiple projectsconcurrently with diverse stakeholders

• Strong organizational skills and ability to prioritize across competing priorities 

• Publications in scientific, academic, or industry journals

• Excellent oral and written communication skills

• Ability to travel (domestic U.S. travel approx. 15-20% annually)

• Management consulting experience is highly desired

The annual base pay for this position ranges from $186,000 to $279,000. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.